Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors
Introduction Diagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family history of hemophilia, diagnosing HB carrier status is challenging. Genetic testing is the gold‐standard, however it is reserved for i...
Saved in:
Published in | Haemophilia : the official journal of the World Federation of Hemophilia Vol. 30; no. 4; pp. 1003 - 1009 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Diagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family history of hemophilia, diagnosing HB carrier status is challenging. Genetic testing is the gold‐standard, however it is reserved for individuals with a high suspicion of carrier status.
Aims
To describe the distribution of activated partial thromboplastin time (aPTT) and factor IX coagulant (FIX:C) levels in HB carriers and assess the ratio of FIX:C to other Vitamin K dependent factors (FII:C, FVII:C, FX:C) as an indicator of HB carrier status.
Methods
In this retrospective, single‐centre cohort study, subjects were included if they were obligate or genetically proven HB carriers. Distributions of aPTT and FIX:C were described and the relationship between FIX:C levels in carriers and severity of familial HB was analysed. Ratios of FIX:C to FII:C, FVII:C, FX:C were calculated.
Results
Seventy‐two female HB carriers (median age: 34 years; IQR 24–43) were included. Median aPTT and FIX:C levels were 33.0 s [IQR 30.0–37.0] and 57 IU/dL [IQR 43–74]. Fifteen carriers (21%) had mild HB (FIX:C levels of 10–40 IU/dL). FIX:C levels trended higher in carriers of mild HB versus carriers of moderate/severe HB. In six carriers, the median ratio of FIX:C to other Vitamin K dependent factors was 0.44, with 92% of ratios being ≤ 0.75.
Conclusion
aPTT and FIX:C levels were unreliable in diagnosing HB carrier status. A low ratio of FIX:C to other Vitamin K dependent factors may be a useful marker of HB carrier status. |
---|---|
AbstractList | Diagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family history of hemophilia, diagnosing HB carrier status is challenging. Genetic testing is the gold-standard, however it is reserved for individuals with a high suspicion of carrier status.
To describe the distribution of activated partial thromboplastin time (aPTT) and factor IX coagulant (FIX:C) levels in HB carriers and assess the ratio of FIX:C to other Vitamin K dependent factors (FII:C, FVII:C, FX:C) as an indicator of HB carrier status.
In this retrospective, single-centre cohort study, subjects were included if they were obligate or genetically proven HB carriers. Distributions of aPTT and FIX:C were described and the relationship between FIX:C levels in carriers and severity of familial HB was analysed. Ratios of FIX:C to FII:C, FVII:C, FX:C were calculated.
Seventy-two female HB carriers (median age: 34 years; IQR 24-43) were included. Median aPTT and FIX:C levels were 33.0 s [IQR 30.0-37.0] and 57 IU/dL [IQR 43-74]. Fifteen carriers (21%) had mild HB (FIX:C levels of 10-40 IU/dL). FIX:C levels trended higher in carriers of mild HB versus carriers of moderate/severe HB. In six carriers, the median ratio of FIX:C to other Vitamin K dependent factors was 0.44, with 92% of ratios being ≤ 0.75.
aPTT and FIX:C levels were unreliable in diagnosing HB carrier status. A low ratio of FIX:C to other Vitamin K dependent factors may be a useful marker of HB carrier status. Introduction Diagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family history of hemophilia, diagnosing HB carrier status is challenging. Genetic testing is the gold‐standard, however it is reserved for individuals with a high suspicion of carrier status. Aims To describe the distribution of activated partial thromboplastin time (aPTT) and factor IX coagulant (FIX:C) levels in HB carriers and assess the ratio of FIX:C to other Vitamin K dependent factors (FII:C, FVII:C, FX:C) as an indicator of HB carrier status. Methods In this retrospective, single‐centre cohort study, subjects were included if they were obligate or genetically proven HB carriers. Distributions of aPTT and FIX:C were described and the relationship between FIX:C levels in carriers and severity of familial HB was analysed. Ratios of FIX:C to FII:C, FVII:C, FX:C were calculated. Results Seventy‐two female HB carriers (median age: 34 years; IQR 24–43) were included. Median aPTT and FIX:C levels were 33.0 s [IQR 30.0–37.0] and 57 IU/dL [IQR 43–74]. Fifteen carriers (21%) had mild HB (FIX:C levels of 10–40 IU/dL). FIX:C levels trended higher in carriers of mild HB versus carriers of moderate/severe HB. In six carriers, the median ratio of FIX:C to other Vitamin K dependent factors was 0.44, with 92% of ratios being ≤ 0.75. Conclusion aPTT and FIX:C levels were unreliable in diagnosing HB carrier status. A low ratio of FIX:C to other Vitamin K dependent factors may be a useful marker of HB carrier status. Diagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family history of hemophilia, diagnosing HB carrier status is challenging. Genetic testing is the gold-standard, however it is reserved for individuals with a high suspicion of carrier status.INTRODUCTIONDiagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family history of hemophilia, diagnosing HB carrier status is challenging. Genetic testing is the gold-standard, however it is reserved for individuals with a high suspicion of carrier status.To describe the distribution of activated partial thromboplastin time (aPTT) and factor IX coagulant (FIX:C) levels in HB carriers and assess the ratio of FIX:C to other Vitamin K dependent factors (FII:C, FVII:C, FX:C) as an indicator of HB carrier status.AIMSTo describe the distribution of activated partial thromboplastin time (aPTT) and factor IX coagulant (FIX:C) levels in HB carriers and assess the ratio of FIX:C to other Vitamin K dependent factors (FII:C, FVII:C, FX:C) as an indicator of HB carrier status.In this retrospective, single-centre cohort study, subjects were included if they were obligate or genetically proven HB carriers. Distributions of aPTT and FIX:C were described and the relationship between FIX:C levels in carriers and severity of familial HB was analysed. Ratios of FIX:C to FII:C, FVII:C, FX:C were calculated.METHODSIn this retrospective, single-centre cohort study, subjects were included if they were obligate or genetically proven HB carriers. Distributions of aPTT and FIX:C were described and the relationship between FIX:C levels in carriers and severity of familial HB was analysed. Ratios of FIX:C to FII:C, FVII:C, FX:C were calculated.Seventy-two female HB carriers (median age: 34 years; IQR 24-43) were included. Median aPTT and FIX:C levels were 33.0 s [IQR 30.0-37.0] and 57 IU/dL [IQR 43-74]. Fifteen carriers (21%) had mild HB (FIX:C levels of 10-40 IU/dL). FIX:C levels trended higher in carriers of mild HB versus carriers of moderate/severe HB. In six carriers, the median ratio of FIX:C to other Vitamin K dependent factors was 0.44, with 92% of ratios being ≤ 0.75.RESULTSSeventy-two female HB carriers (median age: 34 years; IQR 24-43) were included. Median aPTT and FIX:C levels were 33.0 s [IQR 30.0-37.0] and 57 IU/dL [IQR 43-74]. Fifteen carriers (21%) had mild HB (FIX:C levels of 10-40 IU/dL). FIX:C levels trended higher in carriers of mild HB versus carriers of moderate/severe HB. In six carriers, the median ratio of FIX:C to other Vitamin K dependent factors was 0.44, with 92% of ratios being ≤ 0.75.aPTT and FIX:C levels were unreliable in diagnosing HB carrier status. A low ratio of FIX:C to other Vitamin K dependent factors may be a useful marker of HB carrier status.CONCLUSIONaPTT and FIX:C levels were unreliable in diagnosing HB carrier status. A low ratio of FIX:C to other Vitamin K dependent factors may be a useful marker of HB carrier status. IntroductionDiagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family history of hemophilia, diagnosing HB carrier status is challenging. Genetic testing is the gold‐standard, however it is reserved for individuals with a high suspicion of carrier status.AimsTo describe the distribution of activated partial thromboplastin time (aPTT) and factor IX coagulant (FIX:C) levels in HB carriers and assess the ratio of FIX:C to other Vitamin K dependent factors (FII:C, FVII:C, FX:C) as an indicator of HB carrier status.MethodsIn this retrospective, single‐centre cohort study, subjects were included if they were obligate or genetically proven HB carriers. Distributions of aPTT and FIX:C were described and the relationship between FIX:C levels in carriers and severity of familial HB was analysed. Ratios of FIX:C to FII:C, FVII:C, FX:C were calculated.ResultsSeventy‐two female HB carriers (median age: 34 years; IQR 24–43) were included. Median aPTT and FIX:C levels were 33.0 s [IQR 30.0–37.0] and 57 IU/dL [IQR 43–74]. Fifteen carriers (21%) had mild HB (FIX:C levels of 10–40 IU/dL). FIX:C levels trended higher in carriers of mild HB versus carriers of moderate/severe HB. In six carriers, the median ratio of FIX:C to other Vitamin K dependent factors was 0.44, with 92% of ratios being ≤ 0.75.ConclusionaPTT and FIX:C levels were unreliable in diagnosing HB carrier status. A low ratio of FIX:C to other Vitamin K dependent factors may be a useful marker of HB carrier status. |
Author | Bosch, Alessandra Markovic, Teodora Shu, Michael Carcao, Manuel Bouskill, Vanessa Malcolmson, Caroline Wakefield, Cindy |
Author_xml | – sequence: 1 givenname: Michael orcidid: 0000-0003-1940-3734 surname: Shu fullname: Shu, Michael organization: The Hospital for Sick Children – sequence: 2 givenname: Caroline orcidid: 0000-0002-3916-7022 surname: Malcolmson fullname: Malcolmson, Caroline email: caroline.malcolmson@sickkids.ca organization: The Hospital for Sick Children – sequence: 3 givenname: Alessandra surname: Bosch fullname: Bosch, Alessandra organization: The Hospital for Sick Children – sequence: 4 givenname: Teodora surname: Markovic fullname: Markovic, Teodora organization: The Hospital for Sick Children – sequence: 5 givenname: Cindy surname: Wakefield fullname: Wakefield, Cindy organization: The Hospital for Sick Children – sequence: 6 givenname: Vanessa orcidid: 0000-0003-3011-6445 surname: Bouskill fullname: Bouskill, Vanessa organization: The Hospital for Sick Children – sequence: 7 givenname: Manuel orcidid: 0000-0001-5350-1763 surname: Carcao fullname: Carcao, Manuel organization: The Hospital for Sick Children |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38924261$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kV9vFCEUxYmpsX_0wS9gSHyxidPCMMMwvtWm2o1N9GE1vpG7zMWlmYEtsDb76DeXdbcxaZQXCPzOueScY3Lgg0dCXnJ2xss6XwKe8ZZJ9YQccSHbqm65PNieW16pmstDcpzSLWNc1Ew-I4dC9XVTS35Efs0G9NnZjfM_6BKnsFq60QF9Tw3E6DCmd_RrLld5Q4Ol8GU-f0stmBwinX2nI_7EMVHwA42QXUhb6O9zDjTkJUb6zWWYnKef6IAr9NuZeyw9J08tjAlf7PcTMv9wNb-8rm4-f5xdXtxURrRCVWaAFhR02FrorIKFHcC0EtEY2wtRK971rOPc1F0vUVkObKgZCmmVbbqFOCFvdrarGO7WmLKeXDI4juAxrJMWrCvKXqqmoK8fobdhHX35XKEUb1TDWlmoV3tqvZhw0KvoJogb_ZBtAc53gIkhpYhWm5JCCcnnCG7UnOlte7q0p_-0VxSnjxQPpv9i9-73bsTN_0F9fXG1U_wG9vmolg |
CitedBy_id | crossref_primary_10_1177_01939459251325490 |
Cites_doi | 10.1111/hae.14232 10.1111/jth.15397 10.1111/hae.14094 10.1111/j.1538-7836.2012.04653.x 10.1016/B978-0-12-815499-1.00026-0 10.1182/blood-2005-09-3879 10.1002/ajmg.1320260313 10.1097/MBC.0000000000000083 10.1046/j.1365-2141.1999.01631.x 10.1002/rth2.12783 10.3402/fnr.v56i0.5329 10.1111/hae.14046 10.1111/j.1537-2995.2010.02604.x 10.1111/hae.13089 10.1111/jth.15301 10.1055/s-0032-1326786 10.1002/ajh.24709 10.1097/MPH.0000000000000022 10.1111/jth.13294 10.1177/1076029611422364 10.1159/isbn.978-3-318-02198-1 10.1111/hae.13376 10.1111/j.1365-2516.2006.01397.x 10.1111/cge.12709 |
ContentType | Journal Article |
Copyright | 2024 The Author(s). published by John Wiley & Sons Ltd. 2024 The Author(s). Haemophilia published by John Wiley & Sons Ltd. 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2024 The Author(s). published by John Wiley & Sons Ltd. – notice: 2024 The Author(s). Haemophilia published by John Wiley & Sons Ltd. – notice: 2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | 24P AAYXX CITATION NPM 7T5 8FD FR3 H94 K9. P64 RC3 7X8 |
DOI | 10.1111/hae.15068 |
DatabaseName | Wiley Online Library Open Access CrossRef PubMed Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Genetics Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic Genetics Abstracts |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1365-2516 |
EndPage | 1009 |
ExternalDocumentID | 38924261 10_1111_hae_15068 HAE15068 |
Genre | article Journal Article |
GrantInformation_xml | – fundername: Canadian Pediatric Thrombosis and Hemostasis Network |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 24P 29I 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAKAS AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZCM ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBC EBD EBS EBX EGARE EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH YUY ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7T5 8FD AAMMB AEFGJ AGXDD AIDQK AIDYY FR3 H94 K9. P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3538-cda5a8a7e5fa7f8abfdac56eeccf933281790711c2796e8f1a0d20e36f8f47b3 |
IEDL.DBID | DR2 |
ISSN | 1351-8216 1365-2516 |
IngestDate | Fri Jul 11 09:36:51 EDT 2025 Fri Jul 25 10:07:35 EDT 2025 Wed Feb 19 02:06:35 EST 2025 Thu Apr 24 22:50:37 EDT 2025 Tue Jul 01 05:10:53 EDT 2025 Wed Jan 22 17:17:43 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | blood coagulation factors factor IX genetic carrier screening activated partial thromboplastin time hemophilia B |
Language | English |
License | Attribution-NonCommercial-NoDerivs 2024 The Author(s). Haemophilia published by John Wiley & Sons Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3538-cda5a8a7e5fa7f8abfdac56eeccf933281790711c2796e8f1a0d20e36f8f47b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-3011-6445 0000-0003-1940-3734 0000-0001-5350-1763 0000-0002-3916-7022 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhae.15068 |
PMID | 38924261 |
PQID | 3081484056 |
PQPubID | 2045152 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_3072799684 proquest_journals_3081484056 pubmed_primary_38924261 crossref_citationtrail_10_1111_hae_15068 crossref_primary_10_1111_hae_15068 wiley_primary_10_1111_hae_15068_HAE15068 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | July 2024 |
PublicationDateYYYYMMDD | 2024-07-01 |
PublicationDate_xml | – month: 07 year: 2024 text: July 2024 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Chichester |
PublicationTitle | Haemophilia : the official journal of the World Federation of Hemophilia |
PublicationTitleAlternate | Haemophilia |
PublicationYear | 2024 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2021; 27 2006; 108 2017; 92 2016; 90 2022; 6 2020 2021; 19 2014; 36 2014; 25 2020; 26 2012; 18 2012; 38 2013 1996; 58 1999; 106 2012; 56 2007; 13 2016; 14 2012; 10 1987; 26 2010; 50 2016; 22 2018; 24 e_1_2_10_23_1 e_1_2_10_24_1 e_1_2_10_21_1 e_1_2_10_22_1 e_1_2_10_20_1 e_1_2_10_2_1 e_1_2_10_4_1 Becker J (e_1_2_10_8_1) 1996; 58 e_1_2_10_18_1 e_1_2_10_3_1 e_1_2_10_19_1 e_1_2_10_6_1 e_1_2_10_16_1 e_1_2_10_5_1 e_1_2_10_17_1 e_1_2_10_14_1 e_1_2_10_7_1 e_1_2_10_15_1 e_1_2_10_12_1 e_1_2_10_9_1 e_1_2_10_13_1 e_1_2_10_10_1 e_1_2_10_11_1 e_1_2_10_25_1 e_1_2_10_26_1 |
References_xml | – volume: 106 start-page: 870 issue: 4 year: 1999 end-page: 874 article-title: Origin of mutation in sporadic cases of haemophilia A publication-title: Br J Haematol – volume: 22 start-page: 912 issue: 6 year: 2016 end-page: 918 article-title: Evaluation of the utility of the ISTH‐BAT in haemophilia carriers: a multinational study publication-title: Haemophilia – volume: 26 start-page: 1 issue: 6 year: 2020 end-page: 158 article-title: WFH guidelines for the management of hemophilia, 3rd edition publication-title: Haemophilia – volume: 24 start-page: 180 issue: 2 year: 2018 end-page: 185 article-title: The spectrum of bleeding in women and girls with haemophilia B publication-title: Haemophilia – volume: 14 start-page: 953 issue: 5 year: 2016 end-page: 963 article-title: Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms publication-title: J Thromb Haemost – volume: 90 start-page: 63 issue: 1 year: 2016 end-page: 68 article-title: Origin of mutation in sporadic cases of severe haemophilia A in Sweden publication-title: Clin Genet – volume: 38 start-page: 727 issue: 7 year: 2012 end-page: 734 article-title: The diagnosis and management of congenital hemophilia publication-title: Semin Thromb Hemost – volume: 19 start-page: 1883 issue: 8 year: 2021 end-page: 1887 article-title: A new hemophilia carrier nomenclature to define hemophilia in women and girls: communication from the SSC of the ISTH publication-title: J Thromb Haemost – volume: 27 start-page: 293 issue: 2 year: 2021 end-page: 304 article-title: Women and girls with haemophilia and bleeding tendencies: outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review publication-title: Haemophilia – volume: 58 start-page: 657 issue: 4 year: 1996 end-page: 670 article-title: Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type‐dependent sex ratio of mutation frequencies publication-title: Am J Hum Genet – volume: 13 start-page: 90 issue: 1 year: 2007 end-page: 92 article-title: Prevalence of sporadic and familial haemophilia publication-title: Haemophilia – volume: 50 start-page: 1571 issue: 7 year: 2010 end-page: 1580 article-title: Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents publication-title: Transfusion – volume: 26 start-page: 591 issue: 3 year: 1987 end-page: 598 article-title: Reproductive choices in hemophilic men and carriers publication-title: Am J Med Genet – volume: 10 start-page: 615 issue: 4 year: 2012 end-page: 621 article-title: Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders publication-title: J Thromb Haemost – volume: 108 start-page: 52 issue: 1 year: 2006 end-page: 56 article-title: Bleeding in carriers of hemophilia publication-title: Blood – volume: 19 start-page: 1493 issue: 6 year: 2021 end-page: 1505 article-title: Genetic analysis of carrier status in female members of Japanese hemophilia families publication-title: J Thromb Haemost – start-page: 445 year: 2020 end-page: 467 – volume: 92 start-page: E94 issue: 6 year: 2017 end-page: E96 article-title: Utility of factor VIII and factor VIII to von Willebrand factor ratio in identifying 277 unselected carriers of hemophilia A publication-title: Am J Hematol – volume: 56 year: 2012 article-title: Vitamin K: the effect on health beyond coagulation—an overview publication-title: Food Nutr Res – volume: 6 issue: 6 year: 2022 article-title: Challenges and knowledge gaps facing hemophilia carriers today: perspectives from patients and health care providers publication-title: Res Pract Thromb Haemost – volume: 27 start-page: 75 issue: 3 year: 2021 end-page: 81 article-title: Women and girls with haemophilia: lessons learned publication-title: Haemophilia – volume: 18 start-page: 316 issue: 3 year: 2012 end-page: 319 article-title: The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms publication-title: Clin Appl Thromb Hemost – volume: 36 start-page: e224 issue: 4 year: 2014 end-page: e230 article-title: Both hemophilia health care providers and hemophilia a carriers report that carriers have excessive bleeding publication-title: J Pediatr Hematol Oncol – volume: 25 start-page: 471 issue: 5 year: 2014 end-page: 475 article-title: Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B publication-title: Blood Coagul Fibrinolysis – year: 2013 – ident: e_1_2_10_5_1 doi: 10.1111/hae.14232 – ident: e_1_2_10_16_1 doi: 10.1111/jth.15397 – ident: e_1_2_10_7_1 doi: 10.1111/hae.14094 – ident: e_1_2_10_26_1 doi: 10.1111/j.1538-7836.2012.04653.x – ident: e_1_2_10_14_1 doi: 10.1016/B978-0-12-815499-1.00026-0 – ident: e_1_2_10_17_1 doi: 10.1182/blood-2005-09-3879 – ident: e_1_2_10_13_1 doi: 10.1002/ajmg.1320260313 – ident: e_1_2_10_18_1 doi: 10.1097/MBC.0000000000000083 – ident: e_1_2_10_11_1 doi: 10.1046/j.1365-2141.1999.01631.x – ident: e_1_2_10_3_1 doi: 10.1002/rth2.12783 – ident: e_1_2_10_24_1 doi: 10.3402/fnr.v56i0.5329 – ident: e_1_2_10_25_1 doi: 10.1111/hae.14046 – ident: e_1_2_10_23_1 doi: 10.1111/j.1537-2995.2010.02604.x – ident: e_1_2_10_4_1 doi: 10.1111/hae.13089 – ident: e_1_2_10_19_1 doi: 10.1111/jth.15301 – ident: e_1_2_10_2_1 doi: 10.1055/s-0032-1326786 – ident: e_1_2_10_10_1 doi: 10.1002/ajh.24709 – ident: e_1_2_10_15_1 doi: 10.1097/MPH.0000000000000022 – ident: e_1_2_10_22_1 doi: 10.1111/jth.13294 – ident: e_1_2_10_21_1 doi: 10.1177/1076029611422364 – volume: 58 start-page: 657 issue: 4 year: 1996 ident: e_1_2_10_8_1 article-title: Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type‐dependent sex ratio of mutation frequencies publication-title: Am J Hum Genet – ident: e_1_2_10_20_1 doi: 10.1159/isbn.978-3-318-02198-1 – ident: e_1_2_10_6_1 doi: 10.1111/hae.13376 – ident: e_1_2_10_9_1 doi: 10.1111/j.1365-2516.2006.01397.x – ident: e_1_2_10_12_1 doi: 10.1111/cge.12709 |
SSID | ssj0013206 |
Score | 2.4070122 |
Snippet | Introduction
Diagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a... Diagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a family... IntroductionDiagnosing hemophilia B (HB) carrier status is important to manage bleeding in carriers and to prevent bleeding in potential offspring. Without a... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1003 |
SubjectTerms | activated partial thromboplastin time Bleeding blood coagulation factors Coagulation factors factor IX Factor IX deficiency genetic carrier screening Hemophilia hemophilia B Ratios Thromboplastin Vitamin K |
Title | Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fhae.15068 https://www.ncbi.nlm.nih.gov/pubmed/38924261 https://www.proquest.com/docview/3081484056 https://www.proquest.com/docview/3072799684 |
Volume | 30 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIiEutLy3lJVBHDiQVeK8nPa0C10tIFCFtmgPSNHYsdWKNqma7AFu_PN6nActDwlxi-SJnNgz9jf2NzMALyxGV5kvpcel8L1I8dATGQZeVlhnJI65McqxLT4mi6Po3SpebcB-HwvT5ocYDtzIMtx6TQaOsr5i5MeoJ5QejwJ9iatFgOgTv3KD4OpqUgE6T_Ag6bIKEYtnePP6XvQbwLyOV92GM9-CL_2ntjyTr5N1Iyfq-y9ZHP_zX7bhTgdE2bTVnLuwoct7cOtDd9V-H360IbwuDIod67PqnI5ekM2Ywgsqc1fvsaOGmLXfWGUYHi6Xr1hbvYe9XbFTIiPVDMuCOR2rSehnc1MxF_rFPp80eHZSsvesL8fbdGL1A1jOD5avF15Xr8FTIa2bqsAYBaY6NpgagdIUqOJEWy0xWRhyQdnA0iBQPM0SLUyAfsF9HSZGmCiV4UPYLKtSPwaGvlFconUW0bqHfiqLVCQharRrRmExxwhe9hOXqy6XOZXUOM17n8aOaO5GdATPB9HzNoHHn4R2-9nPOxuu89Cipcj6v3EygmdDs7U-ulLBUldrkrH4z7qMIhrBo1Zrhl4sFCT8Qx_r5v7v3eeL6YF72Pl30Sdwm1t81TKHd2GzuVjrpxYfNXIMN3h0OIab09mb2XzszOISUJYMsQ |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9UwEB6VIgEXduiDAgZx4ECeEmdzql4KavVKFyGUondB0dix1aptUjV5B7j1n9fjLLQsEuIWyRM5sWfsb-yZ-QDeWoyuMl9Kj0vhe5HioScyDLystM5IHHNjlIu22E9mB9GneTxfgvUhF6arDzEeuJFluPWaDJwOpK9Y-SHqKdXHEzfgJjF6O4fqC79yh-CYNYmCzhM8SPq6QhTHM756fTf6DWJeR6xuy9m6B9-Gj-0iTY6ni1ZO1Y9f6jj-79_ch7s9FmUbnfI8gCVdPYRbe_1t-yO46LJ4XSYUO9Sn9RmdviD7wBSeE9Nds8YOWgqu_c5qw_Bznr9nHYEP256zE4pHahhWJXNq1pDQz-a2Zi77i309avH0qGI7bGDkbXux5jHkW5v5x5nXUzZ4KqSlU5UYo8BUxwZTI1CaElWcaKsoJgtDLqggWBoEiqdZooUJ0C-5r8PECBOlMnwCy1Vd6RVg6BvFJVp_Ea2H6KeyTEUSoka7bJQWdkzg3TBzherLmROrxkkxuDV2RAs3ohN4M4qedTU8_iS0Okx_0ZtxU4QWMEXWBY6TCbwem60B0q0KVrpekIyFgNZrFNEEnnZqM_Zi0SBBIPpYN_l_776YbWy6h2f_LvoKbs_yvd1id3t_5znc4RZudYHEq7Dcni_0CwuXWvnSWcUlSWUOgw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcoLzahQIGceBAVonzcuip0K62FKoKbdEeKkVjx1Yr2mTVZA9w45_jcR60PCTELZIncmLP2N_YM98AvLQYXWW-lB6XwvcixUNPZBh4WWGdkTjmxigXbXGYTI-j9_N4vgLbfS5Myw8xHLiRZbj1mgx8UZgrRn6Kekz0eOIG3IwSX5BK737iV64QXGFNqkDnCR4kHa0QhfEMr17fjH5DmNcBq9txJnfgpP_WNtDky3jZyLH69guN43_-zDrc7pAo22lV5y6s6PIerH3s7trvw_c2h9flQbFTfVEt6OwF2Vum8JLq3NVv2HFDobVfWWUYHs1mr1lbvoftz9k5RSPVDMuCOSWrSehnc1Mxl_vFPp81eHFWsgPW1-NtOrH6Acwme7N3U68r2OCpkBZOVWCMAlMdG0yNQGkKVHGirZqYLAy5IDqwNAgUT7NECxOgX3Bfh4kRJkpl-BBWy6rUm8DQN4pLtN4iWv_QT2WRiiREjXbRKCzoGMGrfuJy1ZGZU02N87x3auyI5m5ER_BiEF20DB5_EtrqZz_vjLjOQwuXIusAx8kIng_N1vzoTgVLXS1JxgJA6zOKaAQbrdYMvVgsSACIPtbN_d-7z6c7e-7h0b-LPoO1o91J_mH_8OAx3OIWa7VRxFuw2lwu9ROLlRr51NnEDzDKDTs |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identifying+hemophilia+B+carriers%3A+Utility+of+aPTT%2C+factor+IX+levels+and+ratios+of+factor+IX+to+other+Vitamin+K+dependent+factors&rft.jtitle=Haemophilia+%3A+the+official+journal+of+the+World+Federation+of+Hemophilia&rft.au=Shu%2C+Michael&rft.au=Malcolmson%2C+Caroline&rft.au=Bosch%2C+Alessandra&rft.au=Markovic%2C+Teodora&rft.date=2024-07-01&rft.eissn=1365-2516&rft_id=info:doi/10.1111%2Fhae.15068&rft_id=info%3Apmid%2F38924261&rft.externalDocID=38924261 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-8216&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-8216&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-8216&client=summon |